- Home
- OVBC vs NGEN Comparison
OVBC vs NGEN Comparison
Compare OVBC & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | OVBC | NGEN |
|---|---|---|
| Founded | 1872 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.9M | 200.0M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OVBC | NGEN |
|---|---|---|
| Price | $44.71 | $2.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 34.6K | ★ 400.1K |
| Earning Date | 04-28-2026 | 04-02-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | ★ 1.53 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $29.54 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.18 | $1.58 |
| 52 Week High | $51.25 | $5.93 |
Technical Indicators
Market Signals| Indicator | OVBC | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 68.38 |
| Support Level | $44.63 | $1.85 |
| Resistance Level | $47.12 | $2.22 |
| Average True Range (ATR) | 1.29 | 0.09 |
| MACD | 0.16 | 0.05 |
| Stochastic Oscillator | 75.52 | 98.68 |
Price Performance
Historical ComparisonAbout OVBC Ohio Valley Banc Corp.
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.
About NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.